You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selective Androgen Receptor Modulator (SARM)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
Has Results
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Cachexia Trial in Germany, United Kingdom, United States (GSK2881078, Matching Placebo)

Completed
Has Results
  • Cachexia
  • Torrance, California
  • +10 more
Jun 24, 2020

Prostate Cancer Trial in Gainesville, Baltimore, Boston (LY2452473, Placebo)

Completed
Has Results
  • Prostate Cancer
  • Gainesville, Florida
  • +3 more
Sep 27, 2021

Leiomyoma Trial run by the NICHD (ulipristal acetate 20 mg, ulipristal acetate 10 mg, )

Completed
Has Results
  • Leiomyoma
  • ulipristal acetate 20 mg
  • +2 more
  • Bethesda, Maryland
  • +1 more
Feb 14, 2022

Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 5, 2022

Stress Urinary Incontinence Trial in Beijing (EG017 3mg, EG017 6mg)

Completed
  • Stress Urinary Incontinence
  • EG017 3mg
  • EG017 6mg
  • Beijing, Beijing, China
    People's Hospital of Peking University
Dec 30, 2022

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Benign Prostatic Hyperplasia Trial in United States (Group-1 (15mg, OPK-88004), Group-2 (25 mg,OPK-88004), Placebo)

Terminated
Has Results
  • Benign Prostatic Hyperplasia
  • Group-1 (15mg, OPK-88004)
  • +2 more
  • Anniston, Alabama
  • +14 more
Aug 23, 2021

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
Mar 2, 2021

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Cachexia Trial in Overland Park, Baltimore (GSK2881078, Placebo)

Completed
  • Cachexia
  • Overland Park, Kansas
  • +1 more
Jul 20, 2018

Clomiphene Citrate asInhibitor of Ovulation inOocyte

Not yet recruiting
  • Infertility, Female
  • Infertility
  • Baton Rouge, Louisiana
    Womans Hospital
May 17, 2023

Metastatic Breast Cancer Trial in United States (Sabizabulin, Exemestane monotherapy, exemestane plus everolimus, or selective

Not yet recruiting
  • Metastatic Breast Cancer
  • Sabizabulin
  • Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator
  • Anchorage, Alaska
  • +25 more
Dec 22, 2022

Prostate Cancer Trial in United States (ARN-509, LHRH Agonist)

Completed
Has Results
  • Prostate Cancer
  • Scottsdale, Arizona
  • +4 more
Feb 27, 2020

Schizophrenia, Schizophreniform Disorders, Schizo Affective Disorder Trial in Melbourne (Bazedoxifene Acetate, Placebo)

Recruiting
  • Schizophrenia
  • +2 more
  • Bazedoxifene Acetate
  • Placebo
  • Melbourne, Victoria, Australia
    Monash Alfred Psychiatry Research Centre
Jan 6, 2020

Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

Recruiting
  • Breast Cancer Recurrent
  • Palbociclib 125mg
  • Standard endocrine therapy
  • Graz, Austria
  • +52 more
Nov 15, 2022

Leiomyoma Trial run by the NICHD (CDB-2914)

Completed
  • Leiomyoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023

Missed Abortion, Anembryonic Pregnancy, Non-Viable Pregnancy Trial in Chapel Hill, Hillsborough (Ulipristal Acetate Tablets,

Recruiting
  • Missed Abortion
  • +2 more
  • Ulipristal Acetate Tablets
  • Misoprostol Pill
  • Chapel Hill, North Carolina
  • +3 more
Jun 9, 2022

Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Utrecht (Raloxifene, Placebo)

Completed
  • Schizophrenia
  • +3 more
  • Utrecht, Netherlands
    UMC Utrecht
Oct 4, 2021

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

Triple Negative Breast Cancer Trial (Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Seviteronel-D (Seivteronel in combination with dexamethasone)
  • Docetaxel
  • (no location specified)
Sep 21, 2021

Prostate Cancer Trial in Birmingham (Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation

Recruiting
  • Prostate Cancer
  • Abemaciclib 150 MG by mouth twice daily
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham (UAB)
Mar 18, 2022

Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

Recruiting
  • Salivary Gland Cancer
  • Nagoya, Aichi, Japan
  • +11 more
Jan 21, 2023